Efficacy of ciclesonide vs fixed combination of fluticasone propionate/salmeterol vs placebo in patients with mild persistent asthma (12 to 75 y) (BY9010/M1-132)
Study identifier:BY9010/M1-132
ClinicalTrials.gov identifier:NCT00163358
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Efficacy of ciclesonide and of a fixed combination with fluticasone propionate and salmeterol versus placebo on long-term asthma control
Medical condition
asthma
Phase
Phase 3
Healthy volunteers
No
Study drug
Ciclesonide
Sex
All
Actual Enrollment
630
Study type
Interventional
Age
12 Years - 75 Years
Date
Study Start Date: 01 Sept 2003
Primary Completion Date: 01 Oct 2005
Study Completion Date: 01 Oct 2005
Study design
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Oct 2016 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca AstraZeneca
AstraZeneca
